Bare Metal Stents Versus Drug Eluting Stents - How do we Choose?

Authors

  • Gregory Pavlides First Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece

DOI:

https://doi.org/10.2015/hc.v5i1%20Sup.358

Abstract

Percutaneous coronary intervention (PCI) with stent placement has been proven a very effective way to treat patients with significant coronary artery disease (CAD) with acute and chronic clinical coronary syndromes. Over the last 8 years drug-eluting stent (DES) use has surpassed bare metal stent (BMS) use, mainly because DES reduce significantly the in-stent restenosis and decrease future major adverse cardiac events. The use of DES has expanded the application of PCI to more complex CAD patients. The only major, infrequent but critically important, problem with at least the first
generation DES use is the late stent thrombosis and the required long term dual antiplatelet treatment, which is probably due to endothelial dysfunction.... (excerpt)

Author Biography

Gregory Pavlides, First Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece

Specialty: Cardiology

Downloads

Issue

Section

Athens Cardiology Update 2010